Influenza Gateway

Welcome to BioMed Central's Influenza Gateway, highlighting the latest research from BioMed Central journals on influenza-related topics.

Articles

There has been an error retrieving the data. Please try again.
  • Image attributed to: istock

    Low transmission potential of H7N9

    Mathematical models suggest the novel influenza A/H7N9 virus has low transmission potential in China, but continued monitoring is warranted as changing seasonal factors and relaxed interventional measures might promote its spread.

    BMC Medicine 2013, 11:214
  • Image attributed to: Cybercobra on Wikipedia

    Detecting H7 AIVs

    Development of an H7 avian influenza virus (AIV) dual function ELISA, using monoclonal antibodies raised against influenza hemagglutinin, allows sensitive and specific diagnosis of these viruses.

    BMC Microbiology 2013, 13:219
  • Image attributed to: Illustration of rod-shaped bacteria

    Metagenomics and pathogenic detection

    Patrick Tang, Jennifer Gardy and colleagues review metagenomics approaches for pathogen detection in public health settings, which have the potential to revolutionize diagnostic and clinical microbiology.

    Genome Medicine 2013, 5:81
  • Image attributed to: Figure 1

    Anti-viral activity of CHLA & PUG

    Chebulagic acid (CHLA) and punicalagin (PUG), previously shown to inhibit viral glycoprotein interactions with host cells, have been demonstrated to inhibit infection by a number of human pathogens, including hepatitis C virus and dengue virus.

    BMC Microbiology 2013, 13:187
  • Image attributed to: Flickr; Ed Yourdon

    Healthy elderly deficient in Vitamin D

    Approximately two-thirds of healthy Swiss older people have vitamin D insufficiency, and low levels of vitamin D are associated with changes in humoral immunity, providing further evidence for the role of vitamin D in the immune system.

    BMC Medicine 2013, 11:176
  • Image attributed to: James Gathany, Wikimedia Commons

    Cross-reactive influenza epitopes

    This review highlights B and T cell epitopes present in influenza A viruses and their cross reactivity to influenza B viruses, providing an invaluable resource for vaccine development.

    Virology Journal 2013, 10:244
  • Image attributed to: istock photo

    Flu vaccines can provide cross-protection

    Evidence from a systematic review and meta-analysis shows that flu vaccination can protect against infection with a different strain of the virus, but protection is most effective when the vaccine antigens and circulating flu strain match.

    BMC Medicine 2013, 11:153
ez-reprint